title: A vascular protective concept in hypertension and heart failure.
authors.affiliation: F. Hoffmann-La Roche Ltd., Basel, Switzerland.
authors.forename: F R
authors.initials: FR
authors.lastname: Bühler
authors.forename: S G
authors.initials: SG
authors.lastname: Ball
authors.forename: H R
authors.initials: HR
authors.lastname: Baumgartner
authors.forename: G
authors.initials: G
authors.lastname: Ertem
authors.forename: E
authors.initials: E
authors.lastname: Ferrannini
authors.forename: S
authors.initials: S
authors.lastname: Goldstein
authors.forename: Y A
authors.initials: YA
authors.lastname: Karpov
authors.forename: W
authors.initials: W
authors.lastname: Kiowski
authors.forename: T
authors.initials: T
authors.lastname: Widmann
authors.forename: A
authors.initials: A
authors.lastname: Zanchetti
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D065128:Endothelin Receptor Antagonists; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control*; D007333:Insulin Resistance / Q000502:physiology; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality; D012307:Risk Factors
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D065128:Endothelin Receptor Antagonists; D005343:Fibrinolytic Agents; D002784:Cholesterol